Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Library Archives
Volume 4, 2000 Archive

Six issues from 2000 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2000
Vol. 4 No. 1
Compounding for Pain Management
March/April 2000
Vol. 4 No. 2
Compounding for Diabetes Patients
May/June 2000
Vol. 4 No. 3
Compounding for the Ear, Nose and Throat
July/August 2000
Vol. 4 No. 4
Compounding for Hospice and Cancer Patients
September/October 2000
Vol. 4 No. 5
Compounding for Immune System Disorders
November/December 2000
Vol. 4 No .6
Compounding for Hormone Replacement Therapy

Volume 4, 2000 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Jones Marty
Jan/Feb 2000
Pg. 6-15

The Psychology of Pain
Jones Marty
Jan/Feb 2000
Pg. 12-13

Opioids: A Review of the Pharmacology
Ford Peter R
Jan/Feb 2000
Pg. 17-20

Fibromyalgia
Oberlander Kevin
Jan/Feb 2000
Pg. 21-23

Compounding Intrathecal Medications
Vidrine Eric
Jan/Feb 2000
Pg. 24-25

Book Review: The NMDA Receptor
Jones Marty
Jan/Feb 2000
Pg. 26-27

Postherpetic Neuralgia
Angelle Patsy
Jan/Feb 2000
Pg. 27-29

Compounding Software: An Evaluation
Allen Loyd V Jr
Jan/Feb 2000
Pg. 32-35

Marketing Your Prescription Compounding Practice: Part One
Letendre William R
, Jackson Richard A
Jan/Feb 2000
Pg. 36-38

Marketing Tip: Marketing Reps Can Help
Capps Shelly
Jan/Feb 2000
Pg. 39

Profile of a Practice
Davis Jeanie Lerche
Jan/Feb 2000
Pg. 40-41

Particulates in Parenterals
Allen Loyd V Jr
Jan/Feb 2000
Pg. 43

The Basics of Compounding: Compounding Medication Sticks
Allen Loyd V Jr
Jan/Feb 2000
Pg. 44-47

Clear-Stick Base
Allen Loyd V Jr
Jan/Feb 2000
Pg. 45

Styptic Pencil
Allen Loyd V Jr
Jan/Feb 2000
Pg. 45

Styptic Pencil (Crayon Type)
Allen Loyd V Jr
Jan/Feb 2000
Pg. 45

Analgesic Medication Stick
Allen Loyd V Jr
Jan/Feb 2000
Pg. 45

Amitriptyline HCl 2% and Baclofen 2% in PLO
Allen Loyd V Jr
Jan/Feb 2000
Pg. 50

Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO
Allen Loyd V Jr
Jan/Feb 2000
Pg. 51

Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream
Allen Loyd V Jr
Jan/Feb 2000
Pg. 52

Clonidine HCl 1-mg/g in VanPen Cream
Allen Loyd V Jr
Jan/Feb 2000
Pg. 53

Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel
Allen Loyd V Jr
Jan/Feb 2000
Pg. 54

Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches
Allen Loyd V Jr
Jan/Feb 2000
Pg. 55

Fentanyl 50-mcg Chewable Gummy Gels
Allen Loyd V Jr
Jan/Feb 2000
Pg. 56

Fentanyl 25-mcg/0.1-mL Nasal Spray
Allen Loyd V Jr
Jan/Feb 2000
Pg. 57

Morphine Sulfate 2.5-mg/mL Inhalation Solution
Allen Loyd V Jr
Jan/Feb 2000
Pg. 58

Shingles Ointment/Cream
Allen Loyd V Jr
Jan/Feb 2000
Pg. 59

Stiffening Agents, Featured Excipient:
Allen Loyd V Jr
Jan/Feb 2000
Pg. 60-62

Calculations
Prince Shelly J
Jan/Feb 2000
Pg. 63

Calibration of Hot Plates
Allen Loyd V Jr
Jan/Feb 2000
Pg. 64-65

Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Gupta Vishnu D
, Bailey RE
Jan/Feb 2000
Pg. 66-68

Naratriptan HCl in Extemporaneously Compounded Oral Suspensions
Zhang Yanping
, Trissel Lawrence A, Fox Janet L
Jan/Feb 2000
Pg. 69-71

Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
de Villiers Melgardt M
, Narsai Kirti, van der Watt Jakkie G
Jan/Feb 2000
Pg. 72-75

The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert
, Harshbarger Diana
Mar/Apr 2000
Pg. 84-87

Sugar Substitutes
Kloesel Lawson
Mar/Apr 2000
Pg. 86-87

Complications of Diabetes
Key David M
Mar/Apr 2000
Pg. 88-90

Transdermal Gels in the Treatment of Diabetic Neuropathy
Hodges Caroline J
, Jones Thomas H, Willoughby David L
Mar/Apr 2000
Pg. 91-93

L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
Mar/Apr 2000
Pg. 94-96

Natural-Product Therapies for Treating Diabetic Neuropathy
Anderson Constance
Mar/Apr 2000
Pg. 98-100

Patient Handout: Diabetes Management Guidelines
Anderson Constance
Mar/Apr 2000
Pg. 100

Complementary Medicine - A Wellness Plan for People with Diabetes
Singer Debra
Mar/Apr 2000
Pg. 101-102

Diabetes Book Reviews
Reed-Kane Dana
Mar/Apr 2000
Pg. 103-104

Analytical Testing of Extemporaneously Compounded Preparations
Kupiec Thomas C
Mar/Apr 2000
Pg. 105-107

Natural Estrogens: A Review of the Primary Literature
Glasnapp Andrew
Mar/Apr 2000
Pg. 110-114

Marketing Your Prescription Compounding Practice: Part Two
Letendre William R
, Jackson Richard A
Mar/Apr 2000
Pg. 115-117

Profile of a Practice
Davis Jeanie Lerche
Mar/Apr 2000
Pg. 120-121

Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
Mar/Apr 2000
Pg. 122-125

Chlorhexidine 0.2% Oral Rinse
Allen Loyd V Jr
Mar/Apr 2000
Pg. 128

Coenzyme Q10 200-mg Chewable Troches
Allen Loyd V Jr
Mar/Apr 2000
Pg. 129

Diabetic Foot-Care Ointments
Allen Loyd V Jr
Mar/Apr 2000
Pg. 130

Diabetic Skin-Ulcer Cream
Allen Loyd V Jr
Mar/Apr 2000
Pg. 131

Ketamine HCl 5% and Amitriptyline HCl 2% in PLO
Allen Loyd V Jr
Mar/Apr 2000
Pg. 132

Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO
Allen Loyd V Jr
Mar/Apr 2000
Pg. 133

Lipoic Acid 200-mg Chewable Troches
Allen Loyd V Jr
Mar/Apr 2000
Pg. 134

Nifedipine 160-mg/mL in PLO
Allen Loyd V Jr
Mar/Apr 2000
Pg. 135

Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
Mar/Apr 2000
Pg. 136

Vanadyl Sulfate 10-mg Capsules
Allen Loyd V Jr
Mar/Apr 2000
Pg. 137

Official Solvents, Featured Excipient:
Allen Loyd V Jr
Mar/Apr 2000
Pg. 139-142

Standard Operating Procedure for Cleaning Glassware
Allen Loyd V Jr
Mar/Apr 2000
Pg. 144

Calculations
Prince Shelly J
Mar/Apr 2000
Pg. 145

Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution
Kommanaboyina Brahmaiah
, Lindauer Richard F, Rhodes Christopher T, Grady Lee T
Mar/Apr 2000
Pg. 146-149

Effect of Some Antioxidants on the Color Change of White Lotion
Boonme Prapaporn
Mar/Apr 2000
Pg. 154-155

Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration
Inagaki Kazuhiro
, Miyamoto Yuriko, Kurata Niroko, Nakane Shigeki, Gill Mark A, Nishida Mikio
Mar/Apr 2000
Pg. 150-153

Compounding Ear, Nose and Throat Preparations
Allen Loyd V Jr
May/Jun 2000
Pg. 164-169

Benzocaine Otic Solution
Allen Loyd V Jr
May/Jun 2000
Pg. 165

General Nasal Solution Vehicle
Allen Loyd V Jr
May/Jun 2000
Pg. 166

Desmopressin Acetate Nasal Solution 0.033 mg/mL
Allen Loyd V Jr
May/Jun 2000
Pg. 167

Saline Nasal Mist
Allen Loyd V Jr
May/Jun 2000
Pg. 167

Atropine Sulfate 0.5% Nasal Solution
Allen Loyd V Jr
May/Jun 2000
Pg. 167

Xylometazoline 1-mg/mL HCl Nasal Drops
Allen Loyd V Jr
May/Jun 2000
Pg. 169

Progesterone 20-mg/mL Nasal Solution
Allen Loyd V Jr
May/Jun 2000
Pg. 169

Scopolamine Hydrobromide 0.4-mg per 0.1-mL Nasal Solution
Allen Loyd V Jr
May/Jun 2000
Pg. 169

Xylitol in the Prevention of Otitis Media
Glasnapp Andrew
May/Jun 2000
Pg. 171-174

Xylitol 40% Syrup
Allen Loyd V Jr
May/Jun 2000
Pg. 174

Xylitol Troches
Allen Loyd V Jr
May/Jun 2000
Pg. 174

Pilocarpine Oral Solution
Allen Loyd V Jr
May/Jun 2000
Pg. 177

Sildenafil 0.2% Otic Drops
Holland Robert T
, Quisling Richard
May/Jun 2000
Pg. 175

Xerostomia
Kuntz Rachael
, Allen Michelle, Osburn Jennifer
May/Jun 2000
Pg. 176-177

Pharmacological Treatment Options for Snoring
Osburn Jennifer
, Allen Michelle, Kuntz Rachael
May/Jun 2000
Pg. 179

Compounding OTC Drugs: A Legal Perspective
Gibbs Jeffrey N
, Mazan Kate Duffy
May/Jun 2000
Pg. 180-181

Needleless Infusion Systems
Allen Loyd V Jr
, Mathews Elizabeth
May/Jun 2000
Pg. 183

Pharmacy Licensure Requirements
Allen Loyd V Jr
May/Jun 2000
Pg. 186

Wish You Were Here: Oklahoma Frontier Drug Store Museum
Worthen Dennis B
May/Jun 2000
Pg. 188-189

Three Drug Stability Lives
Newton David W
May/Jun 2000
Pg. 190-193

Cellulose Applications for the Pharmaceutical Industry
Nicoll Harold
May/Jun 2000
Pg. 196-197

Marketing Your Prescription Compounding Practice: Part Three
Letendre William R
, Jackson Richard A
May/Jun 2000
Pg. 199-202

Profile of a Practice: Surviving the Competition
Davis Jeanie Lerche
May/Jun 2000
Pg. 203

The Future of Compounding: An Industry Perspective
Capps Shelly
, Winckler Susan C, Anthony Calvin J, Halperin Jerome A
May/Jun 2000
Pg. 204-205

Amphotericin B 100-mg Troches
Allen Loyd V Jr
May/Jun 2000
Pg. 208

Dimethyl Sulfone 16% Nasal Solution
Allen Loyd V Jr
May/Jun 2000
Pg. 209

Miconazole 2% Otic Powder
Allen Loyd V Jr
May/Jun 2000
Pg. 210

Misoprostol 0.001% and Lidocaine 0.5% Oral Rinse
Allen Loyd V Jr
May/Jun 2000
Pg. 211

Misoprostol 0.0027% Mucoadhesive Powder
Allen Loyd V Jr
May/Jun 2000
Pg. 212

Mupirocin 1% Nasal Drops
Allen Loyd V Jr
May/Jun 2000
Pg. 213

Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles
Allen Loyd V Jr
May/Jun 2000
Pg. 214

Saliva Substitute for Dry Mouth/Throat
Allen Loyd V Jr
May/Jun 2000
Pg. 215

Stomatitis Preparations
Allen Loyd V Jr
May/Jun 2000
Pg. 216-217

Tonicity-Adjusting Agents, Featured Excipient:
Allen Loyd V Jr
May/Jun 2000
Pg. 218-220

Calculations
Prince Shelly J
May/Jun 2000
Pg. 221

Assignment of Beyond-Use Dates
Allen Loyd V Jr
May/Jun 2000
Pg. 222

Dry Heat Sterilization of Parenteral Oil Vehicles
Kupiec Thomas C
, Matthews Parrish, Ahmad Riaz
May/Jun 2000
Pg. 223-224

Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs
Roy Julie J
, Hildgen Patrice
May/Jun 2000
Pg. 225-228

Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation
Peh Kok-Khiang
, Tan Yvonne Tze-Fung
May/Jun 2000
Pg. 229-231

Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography
Gupta Vishnu D
May/Jun 2000
Pg. 233-235

Hospice and the Role of the Compounding Pharmacist
Carling Maureen A
Jul/Aug 2000
Pg. 246-249

Nausea and Vomiting in Hospice Patients
Boomsma Diane
Jul/Aug 2000
Pg. 250-251

Ketamine for Pain in Hospice Patients
Wood Robert M
Jul/Aug 2000
Pg. 253-254

Custom-Making Medications for the Hospice Patient
Horwitz Robert
Jul/Aug 2000
Pg. 255-256

Body-Wash Formula
Horwitz Robert
Jul/Aug 2000
Pg. 255

Rinseless Shampoo
Horwitz Robert
Jul/Aug 2000
Pg. 255

Dry Mouth Spray
Horwitz Robert
Jul/Aug 2000
Pg. 255

Surviving Cancer - How the Compounding Pharmacist Can Help
Maddox Suzan
Jul/Aug 2000
Pg. 257-260

Compounding Using Hazardous Drugs
Lau Kellie
Jul/Aug 2000
Pg. 261-263

Providing Positive Outcomes through Compounding for Animal Cancer Patients
Davidson Gigi S
Jul/Aug 2000
Pg. 264-272

Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Glasnapp Andrew
, Schaefer Erin
Jul/Aug 2000
Pg. 276-279

NADH Capsules
Glasnapp Andrew
, Schaefer Erin
Jul/Aug 2000
Pg. 278

Short Communication: Compounding for Implantable Pumps
Molitor Richard
Jul/Aug 2000
Pg. 280

Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
Jul/Aug 2000
Pg. 281-285

Profile of a Practice
Hudson Sonora
Jul/Aug 2000
Pg. 287

Book Reviews
Reed-Kane Dana
Jul/Aug 2000
Pg. 288

Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Allen Loyd V Jr
Jul/Aug 2000
Pg. 289-293

Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection
Allen Loyd V Jr
Jul/Aug 2000
Pg. 296

Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO
Allen Loyd V Jr
Jul/Aug 2000
Pg. 297

Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2000
Pg. 298

Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO
Allen Loyd V Jr
Jul/Aug 2000
Pg. 299

Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution
Allen Loyd V Jr
Jul/Aug 2000
Pg. 300

Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Allen Loyd V Jr
Jul/Aug 2000
Pg. 301

Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations
Allen Loyd V Jr
Jul/Aug 2000
Pg. 302

Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection
Allen Loyd V Jr
Jul/Aug 2000
Pg. 303

Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Allen Loyd V Jr
Jul/Aug 2000
Pg. 304

Ondansetron HCl 8-mg/mL in PLO
Allen Loyd V Jr
Jul/Aug 2000
Pg. 305

Capsule and Tablet Diluents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2000
Pg. 306-310

Basic Compounding Documentation: The Master Formula Form
Tenreiro Kim
Jul/Aug 2000
Pg. 313-312

Calculations
Prince Shelly J
Jul/Aug 2000
Pg. 314

Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion
Al-Achi Antoine
, Greenwood Robert, Akin-Isijola Austin
Jul/Aug 2000
Pg. 315-317

Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs
Jappinen Annaliisa L
, Naaranlahti Toivo J, Kokki Hannu, Ojanen Tarja, Rasi Anu
Jul/Aug 2000
Pg. 318-319

Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution
Fuhrman L Clifton
, Godwin Donald A, Davis R Alan
Jul/Aug 2000
Pg. 320-323

Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Mathews Elizabeth
Sep/Oct 2000
Pg. 334

Clinical Management and Review of Sjogren's Syndrome
Dyke Shannon
Sep/Oct 2000
Pg. 338

Sodium Fluoride Gel (0.5% Fluoride)
Dyke Shannon
Sep/Oct 2000
Pg. 339

Clotrimazole 10 mg Base A Troche
Dyke Shannon
Sep/Oct 2000
Pg. 339

Saliva Substitute
Dyke Shannon
Sep/Oct 2000
Pg. 340

Compounding with Beta-1, 3-D-Glucan
Keller Ted
Sep/Oct 2000
Pg. 342

Psoriasis
Fenrich Jon
, Vidaurri Vincent
Sep/Oct 2000
Pg. 346

Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases
Hinze John
, Mahan Tracy
Sep/Oct 2000
Pg. 349

Immune System Disorders: What's new and Interesting in Print and On-Line
Foy Elizabeth
, MacCara Mary E
Sep/Oct 2000
Pg. 351-353

Transdermal Nifedipine for Wound Healing: Case Reports
Torsiello Michael J
, Kopacki Matthew H
Sep/Oct 2000
Pg. 356

View Sample
Wish You Were Here: Marvin Samson Center for the History of Pharmacy, University of the Sciences in Philadelphia
Worthen Dennis B
Sep/Oct 2000
Pg. 359

Profile of A Practice: Hormone Replacement Therapy in the Heartland
Hudson Sonora
Sep/Oct 2000
Pg. 362

Ambulatory Syringe Infusion Devices: A Review - Part 2
Ashworth Lisa D
Sep/Oct 2000
Pg. 364

Basics of Compounding: Compounding Suppositories Part 2
Allen Loyd V Jr
Sep/Oct 2000
Pg. 371

Artificial Tears for Dry Eyes
Allen Loyd V Jr
Sep/Oct 2000
Pg. 376

Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel
Allen Loyd V Jr
Sep/Oct 2000
Pg. 377

Coal Tar Medication Stick
Allen Loyd V Jr
Sep/Oct 2000
Pg. 378

Interferon with 0.1% Nonoxynol-9 Gel
Allen Loyd V Jr
Sep/Oct 2000
Pg. 379

Interferon Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2000
Pg. 380

Pilocarpine HCl 2-mg Troches
Allen Loyd V Jr
Sep/Oct 2000
Pg. 381

Psoriasis Nail Treatment
Allen Loyd V Jr
Sep/Oct 2000
Pg. 382

Psoriasis Ointment, Heavy Moisturizing
Allen Loyd V Jr
Sep/Oct 2000
Pg. 383

Sunscreen Gel-Alcoholic, SPF-15
Allen Loyd V Jr
Sep/Oct 2000
Pg. 384

Sunscreen Lotion, SPF-40
Allen Loyd V Jr
Sep/Oct 2000
Pg. 385

Providing Care for Diabetic Veterinary Patients
Davidson Gigi S
Sep/Oct 2000
Pg. 386

Capsule and Tablet Lubricants, Featured Excipient:
Allen Loyd V Jr
Sep/Oct 2000
Pg. 390

Calculations
Prince Shelly J
Sep/Oct 2000
Pg. 393

Basic Compounding Documentation: The Batch Control Sheet
Tenreiro Kim
Sep/Oct 2000
Pg. 395

Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
, Ling Jie
Sep/Oct 2000
Pg. 396-397

Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Rose Deidra J
, Webster Andrew A, English Brett A, McGuire J Michael
Sep/Oct 2000
Pg. 398-399

Pharmaceutical Profile of Vitamin C Tablets and Capsules
Al-Achi Antoine
, Greenwood Robert, Nzazi Guy
Sep/Oct 2000
Pg. 400-403

Correction
Sep/Oct 2000
Pg. 330

"Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach
Drisko Jeanne A
Nov/Dec 2000
Pg. 414-420

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina
, Garcia Lea
Nov/Dec 2000
Pg. 421-422

Book Reviews: Women's Health
Reed-Kane Dana
Nov/Dec 2000
Pg. 424-425

Hormone Replacement Therapy: Selected Recent References
Foy Elizabeth
, MacCara Mary E
Nov/Dec 2000
Pg. 426-427

Testosterone Deficiency in Men: New Treatments for Andropause
Biundo Bruce
, Shippen Eugene
Nov/Dec 2000
Pg. 429-431

Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists
Cutter Christopher B
Nov/Dec 2000
Pg. 432-437

View Sample
Zinc Sulfate Heptahydrate 0.1% Solution
Allen Loyd V Jr
Nov/Dec 2000
Pg. 440

Managing Zinc Deficiency in an Office Setting
Norwood Charles
, Chaney Bill, Moore Robert W
Nov/Dec 2000
Pg. 440-441

Disposable Ambulatory Infusion Devices: A Review - Part 3
Ashworth Lisa D
Nov/Dec 2000
Pg. 442-443

On-Line Billing for Custom Compounds: The Third-Party Payor
Heckman H Edward
Nov/Dec 2000
Pg. 445-446

Fentanyl Troche Protocol
Roberts Bruce T
Nov/Dec 2000
Pg. 447

Profile of a Practice: Med Specialties Pharmacy
Mathew Brina
Nov/Dec 2000
Pg. 448-449

Wish You Were Here: Donald F. Salvatori California Pharmacy Museum
Worthen Dennis B
Nov/Dec 2000
Pg. 450-451

Basics of Compounding - Inhalation Preparations
Allen Loyd V Jr
Nov/Dec 2000
Pg. 452-455

Albuterol Sulfate 0.5% Inhalant Solution (Preservative Free)
Allen Loyd V Jr
Nov/Dec 2000
Pg. 455

Flunisolide 0.025% Inhalation Solution (Preservative Free)
Allen Loyd V Jr
Nov/Dec 2000
Pg. 455

Ipratropium Bromide 0.02% Solution (Preservative Free)
Allen Loyd V Jr
Nov/Dec 2000
Pg. 455

Terbutaline 0.1% Inhalant Solution (Preservative Free)
Allen Loyd V Jr
Nov/Dec 2000
Pg. 455

Albuterol-Cromolyn-Betamethasone for Inhalation (Preservative Free)
Allen Loyd V Jr
Nov/Dec 2000
Pg. 455

Albuterol-Ipratropium for Inhalation (Preservative Free)
Allen Loyd V Jr
Nov/Dec 2000
Pg. 455

Beclomethasone Dipropionate 0.042% Nasal Solution (Preservative Free)
Allen Loyd V Jr
Nov/Dec 2000
Pg. 455

Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules
Allen Loyd V Jr
Nov/Dec 2000
Pg. 458

Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules
Allen Loyd V Jr
Nov/Dec 2000
Pg. 459

Estrogen 0.625-mg/5-g Vaginal Gel
Allen Loyd V Jr
Nov/Dec 2000
Pg. 460

Progesterone Cycle Pack 35/50/75/100-mg Capsules
Allen Loyd V Jr
Nov/Dec 2000
Pg. 461

Testosterone 1-mg/0.1-mL Nasal Spray
Allen Loyd V Jr
Nov/Dec 2000
Pg. 462

Testosterone 1-mg/0.1-mL in a PLO Gel
Allen Loyd V Jr
Nov/Dec 2000
Pg. 463

Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray
Allen Loyd V Jr
Nov/Dec 2000
Pg. 464

Triple Estrogen 2.5-mg/0.1-mL PLO
Allen Loyd V Jr
Nov/Dec 2000
Pg. 465

Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
Nov/Dec 2000
Pg. 466

Triple Estrogen 2.5-mg Tablet Triturates
Allen Loyd V Jr
Nov/Dec 2000
Pg. 467

Estrogen Use in Dogs: Indications and Complications
Davidson Gigi S
Nov/Dec 2000
Pg. 468-470

Oleaginous Vehicles, Featured Excipient:
Allen Loyd V Jr
Nov/Dec 2000
Pg. 470-472

Calculations
Prince Shelly J
Nov/Dec 2000
Pg. 473

Assignment of a Beyond-Use Date for Compounded Preparations
Allen Loyd V Jr
Nov/Dec 2000
Pg. 474-475

Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate
Xu Quanyun A
, Trissel Lawrence A, Zhang Yanping, Williams Kimberly Y
Nov/Dec 2000
Pg. 476-479

Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
, Ling Jie
Nov/Dec 2000
Pg. 480-481

Stability of Levothyroxine Sodium Injection in Polypropylene Syringes
Gupta Vishnu D
Nov/Dec 2000
Pg. 482-483

Return to Top